Flibanserin can be safely added to a stable SSRI or SNRI regimen to treat hypoactive sexual desire disorder.
Men, including male physicians, are less likely than female physicians to seek medical treatment for their own health conditions.
Flibanserin may improve some measures of sexual dysfunction in premenopausal women.
A clinician should also rule out the possibility that the dysfunction stems from a co-occurring medical or psychiatric condition, or substance abuse.
Awareness of adolescents' sexual history is essential in providing mental health treatment.
Researchers found that the brains of those with compulsive sexual behaviors "lit up" in the same way as drug addicts' brains.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Psychopathology of Adults Affected by Pre- and Perinatal Factors, Family Functioning
- Anxiety: Feature of Late-Onset Dementia or Modifiable Risk Factor?
- New APA President Takes Office as the First African-American to Lead the Organization
- Concise Questionnaire Found Consistent, Reliable at Monitoring OCD
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- HIV Viral Suppression Rates in Psychiatric Inpatients With Comorbid Substance Use Disorders
- Greater Wealth Associated With Lower Risk for Dementia in English Study
- Social Hygiene: Screening for Social Media Addiction in Adolescent Patients
- Effects of Depressive Symptoms on Cognition, Markers of Brain Aging
- Substance Abuse and Primary Psychosis: A Closer Look